BSE 500 News and Updates

Keep track of all breaking news on BSE 500 from all sources in a single place.

Load latest

ACC Ltd.

24 Apr 2025, 03:22PM

2066.20

0.70%

to see Rapid results content

HCL Technologies Ltd.

24 Apr 2025, 02:58PM

1586.70

-0.46%

Indian IT firms use AI to drive sales growth with fewer new hires

Business Standard

HCL Technologies Ltd. and LTIMindtree Ltd. are among companies saying they need fewer new staff to keep revenue increasing

ICICI Securities Limited decreased Sell price target of HCL Technologies Ltd. to 1390.0 on 23 Apr, 2025.

Nestle India Ltd.

24 Apr 2025, 02:43PM

2433.20

-0.01%

Nestle India Q4FY25 results: Profit drops 6.5% to 873 crore, sales up 3.7%

Business Standard

Nestle India Ltd on Thursday reported 6.5 per cent decline in consolidated net profit at Rs 873.46 crore for March quarter FY25 as the FMCG industry faced food inflation and moderation in urban consumption. The company posted a profit of Rs 934.17 crore for the January-March period a year ago, according to a regulatory filing from Nestle India. Revenue from the sale of products was up at Rs 5,447.64 crore in the quarter as against Rs 5,254.43 crore a year ago. "Total sales and domestic sales for the quarter increased 3.7 per cent and 4.2 per cent, respectively. Domestic sales growth was broad-based. Domestic sales crossed Rs 5,235 crore, the highest ever, surpassing that of JanuaryMarch 2024 quarter," said Nestle India, which owns popular brands as Maggi, Nescafe and Kit Kat. However, exports were down 8.65 per cent to Rs 212.66 crore in Q4 FY25 due to commodity headwinds in coffee. In March quarter, total expenses of Nestle India were at Rs 4,307.76 crore. Revenue from operation

Nestle India Ltd. is trading at high day volume of 2.3M.

Nestle India announces Rs 10 final dividend. Check record date, other details

Economic Times | 24 Apr 2025, 12:39PM 4 more

UltraTech Cement Ltd.

24 Apr 2025, 02:42PM

12159.00

1.76%

Cement shares rally up to 5%, UltraTech, JK hit record highs; here's why

Business Standard

With the monsoon still two months away, cement companies stand to benefit from this seasonally strong period.

UltraTech Cement Ltd. has an average target of 12844.09 from 12 brokers.

Supreme Petrochem Ltd.

24 Apr 2025, 02:29PM

647.05

2.15%

Supreme Petrochem shares climb 5% on Q4FY25 results, dividend news; details

Business Standard

The movement in the company's share price came on the back of the company's announcement of its quarterly earnings for the fourth quarter of the financial year 2024-25 (FY25)

Supreme Petrochem Ltd. is trading below its 150 day SMA of 687.8

Supreme Industries Ltd.

24 Apr 2025, 02:25PM

3511.70

-0.41%

to see Rapid results content

Minda Corporation Ltd.

24 Apr 2025, 02:08PM

516.10

-0.77%

Minda Corp's stake in JV with Furukawa Electric reduced to 17.54%

Business Line

Minda Corporation enters into a share subscription agreement with Furukawa Electric Company Ltd and Furukawa Automotive Systems Inc

Minda Corporation Ltd. is trading below all available SMAs

Lupin Ltd.

24 Apr 2025, 01:55PM

2104.10

0.70%

Lupin gets USFDA nod for generic kidney disease treatment drug Tolvaptan

Business Standard

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease. The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Tolvaptan tablets of strengths 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg, Lupin said in a regulatory filing. These are bioequivalent to Jynarque tablets in the same strengths of Otsuka Pharmaceutical Company Ltd, it added. "Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin's Nagpur facility and will be launched soon," the company said. Commenting on the approval, Lupin CEO Vinita Gupta said,"This marks a significant entry into the nephrology segment and demonstrates our commitment to addressing the unmet needs of patients globally." Tolvaptan is indicated to slow kidney function decline in .

Lupin Ltd. has gained 33.17% in the last 1 Year

Lupin gets USFDA nod for generic kidney disease treatment drug

Business Line | 24 Apr 2025, 01:14PM

Devyani International Ltd.

24 Apr 2025, 01:46PM

179.16

2.03%

Devyani International to acquire 80.72% stake in Sky Gate

Business Line

DIL to acquire a controlling stake in Sky Gate Hospitality Private Limited along with its three brands which include Biryani by Kilo', Goila Butter Chicken', and The Bhojan'

Number of FII/FPI investors increased from 164 to 179 in Mar 2025 qtr.

Syngene International Ltd.

24 Apr 2025, 01:33PM

653.40

-12.78%

Syngene International Results Earnings Call for Q4FY25 & Full Year

Conference Call with Syngene International Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Is BSE 500 worth buying?

15 Votes:

Buy 66.67%

Sell 13.33%

Hold 20.0%

BSE 500 PB	3.9
BSE 500 PE	23.3
BSE 500 DIV	1.1
BSE 500 EPS	1,498.6

52W Low on Apr 07, 2025

BSE 500 PB

BSE 500 PE

BSE 500 DIV

BSE 500 EPS

BSE 500 News and Updates

Keep track of all breaking news on BSE 500 from all sources in a single place.